S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Rockwell Medical to Host Investor Meeting With Nephrology Key Opinion Leader on March 6, 2014 in New York City (2014/3/5)|
|Rockwell Medical Submits New Drug Application for Triferic(TM) for the Treatment of Iron Replacement in Chronic Kidney Disease Patients on Hemodialysis (2014/3/24)|
|Rockwell Medical Reports Second Quarter 2013 Results ()|
|Rockwell Medical Reports Third Quarter 2013 Results (2013/11/5)|
|Rockwell Medical, Inc. Reports Fourth Quarter 2013 Results (2014/2/26)|
|Rockwell Medical Announces SFP Meets Primary and Key Secondary Endpoints in Phase 3 CRUISE-2 Efficacy Study as a Treatment for Iron Replacement in Chronic Kidney Disease Patients on Dialysis ()|
|Rockwell Medical Completes Long-Term Safety Study for Iron Maintenance Drug Triferic(TM) (2014/2/4)|
|Rockwell Medical Announces Triferic(TM) PRIME ESA Sparing Study Selected as Best Abstract at 34th Annual Dialysis Conference in Atlanta, GA, February 8-11, 2014 ()|
|Rockwell Medical Schedules 4th Quarter 2013 Investor Conference Call (2014/2/18)|
|Rockwell Medical to Discuss Top-Line Results From Final SFP Phase 3 Efficacy Study CRUISE-2 (2013/9/3)|
Click above to view more mutual fund data and stats for rmti - Rockwell Medical Inc.